News
VRAX
2.840
-1.39%
-0.040
Weekly Report: what happened at VRAX last week (0803-0807)?
Weekly Report · 1d ago
Virax Biolabs and Transcode Therapeutics Interviews to Air Nationally on the RedChip Small Stocks, Big Money(TM) Show on CNBC and Bloomberg TV
Barchart · 4d ago
Weekly Report: what happened at VRAX last week (0727-0731)?
Weekly Report · 08/03 09:38
Virax Biolabs Calls August 14 EGM to Approve Major Share Capital Increase
TipRanks · 07/31 12:17
Weekly Report: what happened at VRAX last week (0720-0724)?
Weekly Report · 07/27 09:41
Virax Biolabs files to sell 1.68M ordinary shares for holders
TipRanks · 07/24 20:25
Virax Biolabs Files Prospectus For Offering 1.682M Ordinary Shares
Benzinga · 07/24 20:23
Weekly Report: what happened at VRAX last week (0713-0717)?
Weekly Report · 07/20 09:39
Virax Biolabs Boosts Liquidity, Secures Fosun Deal and Restores Nasdaq Compliance After Fiscal 2026 Report
TipRanks · 07/17 08:48
Top Biotech Gainers: CDNA Soars On Medicare Policy, ATAI Acquired, ABT Lifts Outlook, APLM On Watch
NASDAQ · 07/17 02:52
Why is Cathie Wood’s ARK Fund Backing this Israeli Innovator? (NASDAQ: MDWD)
TipRanks · 07/16 13:00
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Benzinga · 07/16 12:05
Virax Biolabs Management Believes Current Valuation Doesn't Fully Reflect Its Audited Financial Position, Clinical And Development Programs, Commercial Progress Or Strategic Assets
Benzinga · 07/16 11:41
Weekly Report: what happened at VRAX last week (0706-0710)?
Weekly Report · 07/13 09:40
Virax Biolabs Raises $3.3 Million via Exercise of Investment Options and Issues New Warrants
TipRanks · 07/10 20:27
Virax Biolabs Group Limited Announces Closing of Exercise of Preferred Investment Options for $3.3 Million Gross Proceeds
PR Newswire · 07/10 20:05
12 Health Care Stocks Moving In Friday's Intraday Session
Benzinga · 07/10 17:05
Dow Gains 50 Points; Simulations Plus Earnings Top Views
Benzinga · 07/10 16:38
Weekly Buzz: JNJ, VERA Get FDA Nod; VRTX Snaps Up CRNX; MSLE Aces DMD Trial; IONS Misses Key Goal
NASDAQ · 07/10 16:10
US Stocks Edge Higher; Delta Air Lines Posts Upbeat Q2 Earnings
Benzinga · 07/10 13:44
More
Webull provides a variety of real-time VRAX stock news. You can receive the latest news about Virax Biolabs Group Ltd through multiple platforms. This information may help you make smarter investment decisions.
About VRAX
Virax Biolabs Group Limited is a biotechnology company focused on the detection of immune responses to and diagnosis of viral diseases. The Company is engaged in developing ViraxImmune with the intention of providing an immunology profiling platform that assesses each individual’s immune risk profile against global viral diseases as well as helping with the early diagnosis of post-viral syndromes associated with T cell exhaustion and chronic inflammation. Its product portfolio includes ViraxClear and ViraxVet. ViraxClear offers a range of accurate diagnostic testing kits and machines. ViraxVet offers various rapid and molecular tests for small animal veterinary diagnostics. The Company is initially focused on diseases associated with post-viral syndromes, including SARS-CoV-2, Human Papillomavirus (HPV), Malaria, Hepatitis B, and Herpes (HSV-1).